Literature DB >> 1981021

Electrophysiologic effects of intravenous xamoterol in patients with sinus node dysfunction.

M de Marneffe1, P Waterschoot, A Bernard, P Dubois, F Boujelben, I Liebens, M Englert.   

Abstract

The electrophysiologic effects of xamoterol were studied in ten patients with electrophysiologic evidence of sinus node dysfunction. A significant shortening of mean sinus cycle length, maximal corrected sinus-node recovery time, and the mean of the three longest corrected sinus-node recovery times was observed after intravenous administration of 0.1 mg/kg of xamoterol. The atrioventricular (AV) conduction time and the effective and functional refractory periods of the AV node were shortened as the effective refractory period of the atrium. These effects suggest that xamoterol could be tried safely for the treatment of patients with moderate symptoms due to sinus-node disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981021     DOI: 10.1007/bf01857764

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  29 in total

1.  Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction.

Authors:  H C Strauss; M Gilbert; R H Svenson; H C Miller; A G Wallace
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

2.  Significance of the sinus-node recovery time.

Authors:  O S Narula; P Samet; R P Javier
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

3.  Hemodynamic effects of Corwin (ICI 118,587), a new cardioselective beta-adenoceptor partial agonist.

Authors:  J M Detry; P M Decoster; L A Brasseur
Journal:  Eur Heart J       Date:  1983-08       Impact factor: 29.983

4.  Effects of intrinsic sympathetic activity of beta-blockers on SA and AV nodes in man.

Authors:  J F Leclercq; M D Rosengarten; S Kural; P Attuel; P Coumel
Journal:  Eur J Cardiol       Date:  1981

5.  Cardiac pacing and pacemaker. I. Indications for pacing bradyarrhythmias.

Authors:  S Furman
Journal:  Am Heart J       Date:  1977-04       Impact factor: 4.749

6.  Hydralazine in the management of symptomatic sinus bradycardia.

Authors:  A T Weiss; J L Rod; M S Gotsman; B S Lewis
Journal:  Eur J Cardiol       Date:  1981

7.  Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol.

Authors:  G Jennings; A Bobik; C Oddie; R Restall
Journal:  Clin Pharmacol Ther       Date:  1984-05       Impact factor: 6.875

8.  Beta-adrenoceptor antagonists increase sinus arrhythmia, a vagotonic effect.

Authors:  S B Bittiner; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

9.  Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction.

Authors:  M F Rousseau; H Pouleur; M F Vincent
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

10.  Studies on the mechanism of sinus node dysfunction in the sick sinus syndrome.

Authors:  J L Jordan; I Yamaguchi; W J Mandel
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.